TAAR1 and immunodeficiency disease: The above biological actions may also contribute to explaining the therapeutic efficacy of Tα1 in other physio-pathological conditions associated with immunological dampening and persistent inflammation, such as chronic viral hepatitis, severe sepsis, primary or acquired immuno-deficiencies and aging [13].